IL32 and atherosclerosis: There is also evidence supporting IL-32′s involvement in atherosclerosis pathogenesis, as an increased IL-32 expression has been observed in arterial plaques from patients, and studies in IL-32γ transgenic mice have demonstrated early arteriosclerotic damage [49].